« Back to Record
Citation APA

Roumeguere, T., Zouaoui Boudjeltia, K., Hauzeur, C., Schulman, C., Vanhaeverbeek, M., & Wespes, E. (2009). Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? BJU international, 104(4), 511-517. doi:10.1111/j.1464-410X.2009.08418.x


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/148145

Roumeguere, T., Zouaoui Boudjeltia, K., Hauzeur, C., Schulman, C., Vanhaeverbeek, M., & Wespes, E. (2009). Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia? BJU international, 104(4), 511-517. doi:10.1111/j.1464-410X.2009.08418.x